Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Oct 4;8 Spec No A(Spec Iss A):S27-31.
doi: 10.1102/1470-7330.2008.9006.

PET/CT for staging and monitoring non small cell lung cancer

Affiliations
Review

PET/CT for staging and monitoring non small cell lung cancer

Sheila Rankin. Cancer Imaging. .

Abstract

Correct staging of non small cell lung cancer (NSCLC) is vital for appropriate management. Initial staging is usually performed with computerised tomography (CT), but increasingly functional imaging using integrated positron emission tomography and CT (PET/CT) is being used to provide more accurate staging, guide biopsies, assess response to therapy and identify recurrent disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient with NSCLC. PET/CT shows central tumour separate from distal consolidation.
Figure 2
Figure 2
(a) NSCLC on the left with involved subcarinal (N2) nodes. (b) Same patient with involved right superior mediastinal nodes (N3), which are normal in size on CT.
Figure 3
Figure 3
(a) PET/CT shows uptake in the thoracic vertebra which is not identified on the diagnostic CT. (b) Same patient. Metastasis is seen on the MRI.
Figure 4
Figure 4
Recurrent disease shown on PET/CT in a patient who developed a broncho-pleural fistula 6 months after pneumonectomy.

Similar articles

Cited by

References

    1. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007;2:706–14. - PubMed
    1. Yang SN, Liang JA, Lin FJ, Kwan AS, Kao CH, Shen YY. Differentiating benign and malignant pulmonary lesions with FDG-PET. Anticancer Res. 2001;21:4153–7. - PubMed
    1. van Baardwijk A, Baumert BG, Bosmans G, et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev. 2006;32:245–60. - PubMed
    1. Shim SS, Lee KS, Kim BT. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology. 2005;236:1011–9. - PubMed
    1. Bryant AS, Cerfolio RJ, Klemm JM, Ohja B. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Ann Thorac Surg. 2006;82:417–22. - PubMed

LinkOut - more resources